Changes in somatotropic axis response and body composition during growth hormone administration in progressive cachectic parasitism.
A multistage protozoan parasitic disease was used as a cachexia model to study the effects of daily administration of bovine growth hormone (GH) on endocrine and body composition changes of young calves from the onset of the acute phase response (APR). Male calves averaging 127.5 +/- 2.0 kg body weight were assigned to control, ad libitum fed, noninfected (C); ad libitum fed, infected (250,000 oocysts Sarcocystis cruzi, per os, I); noninfected, pair-fed (PF) to matched I-treatment calves and these respective same treatments in calves injected daily with GH (USDA-bGH-B1), 12.5 mg/calf/day, im) designated as CGH, IGH and PFGH. GH injections were initiated on Day 20 postinfection (PI), 3 to 4 d before the onset of clinical signs of APR, and continued to Day 56 PI, at which time animals were euthanized for tissue collections. Abrupt increases in rectal temperature commensurate with up to 70% reduction in voluntary feed intake were observed in I and IGH beginning 23-25 d PI. For the trial period between Days 20 and 56 PI, average daily carcass protein gains were 123, 52, 109, 124, 48, and 67 g/d and average daily carcass fat gains were 85, 11, 43, 71, -23, and 29 g/d for C, I, PF, CGH, IGH, and PFGH, respectively. Effects of GH were significant for fat accretion and plasma urea depression. Rectus femoris was highly refractory to catabolic effects of infection while psoas major was significantly catabolized during infection. Plasma concentrations of insulin-like growth factor-I (IGF-I) increased significantly in all GH-treated calves between Day 20 and 23 PI. Plasma IGF-I declined well below Day 20 values in all infected calves from the onset of the APR through the end of the study. The decrease in plasma IGF-I concentrations in I and IG was highly correlated with the magnitude of the fever response. Hepatic mRNA for GH receptor and IGF-I was decreased in infected calves. Hepatic microsomal membrane binding of 125I-GH did not differ between groups. The data suggest that effects of GH and parasitism on tissue metabolism during disease may vary among different specific tissue pools. The data demonstrate that daily GH administration in young calves does not prevent lean tissue losses and may accelerate fat depletion associated with cachectic parasitism. Furthermore, the onset of APR overrode the capacity for GH to maintain elevated plasma concentrations of IGF-I, an effect not readily explained through changes of GH-receptor binding.
US Department of Agriculture, Agriculture Research Service, Beltsville, MD 20705 USA.
T H
TH
Elsasser
J L
JL
Sartin
C
C
McMahon
G
G
Romo
R
R
Fayer
S
S
Kahl
B
B
Blagburn
D000210:Acute-Phase Reaction / Q000097:blood / Q000503:physiopathology / Q000662:veterinary; D000818:Animals; D001806:Blood Urea Nitrogen; D001823:Body Composition / Q000187:drug effects* / Q000502:physiology; D001831:Body Temperature / Q000187:drug effects; D002100:Cachexia / Q000209:etiology / Q000517:prevention & control / Q000662:veterinary*; D002417:Cattle; D002418:Cattle Diseases / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control; D013006:Growth Hormone / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D013007:Growth Hormone-Releasing Hormone / Q000494:pharmacology; D007334:Insulin-Like Growth Factor I / Q000032:analysis / Q000235:genetics; D008297:Male; D008862:Microsomes, Liver / Q000378:metabolism; D009124:Muscle Proteins / Q000187:drug effects / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D011986:Receptors, Somatotropin / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D012523:Sarcocystosis / Q000150:complications / Q000503:physiopathology / Q000662:veterinary*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D015430:Weight Gain / Q000187:drug effects
D009124:Muscle Proteins; D012333:RNA, Messenger; D011986:Receptors, Somatotropin; D014409:Tumor Necrosis Factor-alpha; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone